Relationship between hippocampal atrophy and neuropathology markers: A 7T MRI validation study of the EADC-ADNI harmonized hippocampal segmentation protocol

Alzheimer's and Dementia

Volumn 11, Issue 2, 2015, Pages 139-150

  Apostolova, Liana G ^a   Zarow, Chris ^b   Biado, Kristina ^c   Hurtz, Sona ^d   Boccardi, Marina ^e   Somme, Johanne ^f   Honarpisheh, Hedieh ^g   Blanken, Anna E ^a   Brook, Jenny ^c   Tung, Spencer ^c   Kraft, Emily ^l   Lo, Darrick ^c   Ng, Denise ^c   Alger, Jeffry R ^a   Vinters, Harry V ^a,c   Bocchetta, Martina ^e,h   Duvernoy, Henri ⁱ   Jack, Clifford R ^j   Frisoni, Giovanni B ^e,k   Bartzokis, George ^a   Csernansky, John G ^m   De Leon, Mony J ⁿ   Detoledo Morrell, Leyla ^o   Killiany, Ronald J ^p   Lehericy, Stephane ^q   Malykhin, Nikolai ^r   Pantel, Johannes ^s   Pruessner, Jens C ^t   Soininen, Hilkka ^u   Watson, Craig ^v   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SAN FRANCISCO STATE UNIVERSITY   (United States)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^f HOSPITAL TXAGORRITXU   (Spain)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF BRESCIA   (Italy)

ⁱ Mayo Clinic and Foundation ^*  (France)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF GENEVA   (Switzerland)

^l UNIVERSITY OF ROCHESTER   (United States)

^m NORTHWESTERN UNIVERSITY   (United States)

ⁿ NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o RUSH MEDICAL COLLEGE   (United States)

^p BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^q SORBONNE UNIVERSITÉ   (France)

^r UNIVERSITY OF ALBERTA   (Canada)

^s GOETHE UNIVERSITY   (Germany)

^t MCGILL UNIVERSITY   (Canada)

^u KUOPIO UNIVERSITY HOSPITAL   (Finland)

^v DETROIT RECEIVING HOSPITAL   (United States)

more..

Author keywords

Alzheimer; Amyloid; Atrophy; Braak; CERAD; Dementia; Hippocampal atrophy; Hippocampal segmentation; Hippocampal volumes; Hippocampus; Neuronal count; Pathology; Subfields; Tau; Validation

Indexed keywords

AMYLOID BETA PROTEIN; BENZOXAZINE DERIVATIVE; CRESYL VIOLET; MAPT PROTEIN, HUMAN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; BRAIN WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE HILUS; FEMALE; HARMONIZED HIPPOCAMPAL SEGMENTATION PROTOCOL; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SUBICULUM; TEMPORAL LOBE; VALIDATION STUDY; ATROPHY; CELL COUNT; DEVICES; IMAGE PROCESSING; METABOLISM; MIDDLE AGED; NERVE CELL; ORGAN SIZE; PATHOLOGY; PROCEDURES; VERY ELDERLY;

AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; BENZOXAZINES; CELL COUNT; FEMALE; HIPPOCAMPUS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; ORGAN SIZE; TAU PROTEINS; TEMPORAL LOBE;

EID: 84933528417     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2015.01.001     Document Type: Article

References (55)

1. Shim YS, Roe CM, Buckles VD, Morris JC. Clinicopathologic study of Alzheimer's disease: Alzheimer mimics. J Alzheimers Dis 2013; 35:799-811.
2. Beach TG, Monsell SE, Phillips LE, Kukull W. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. J Neuropathol Exp Neurol 2012; 71:266-73.
3. Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, et al. Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA 2011;305:275-83.
4. Clark CM, Pontecorvo MJ, Beach TG, Bedell BJ, Coleman RE, Doraiswamy PM, et al. Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-beta plaques: A prospective cohort study. Lancet Neurol 2012;11:669-78.
5. Apostolova LG, Dinov ID, Dutton RA, Hayashi KM, Toga AW, Cummings JL, et al. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 2006; 129:2867-73.
6. Apostolova LG, Dutton RA, Dinov ID, Hayashi KM, Toga AW, Cummings JL, et al. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps. Arch Neurol 2006;63:693-9.
7. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, RamirezA, et al. Subregional hippocampal atrophy predictsAlzheimer's dementia in the cognitively normal. Neurobiol Aging 2010;31:1077-88.
8. Apostolova LG, Thompson PM, Green AE, Hwang KS, Zoumalan C, Jack CR Jr, et al. 3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI. Hum Brain Mapp 2010;31:786-97.
9. Chetelat G, Fouquet M, Kalpouzos G, Denghien I, De la Sayette V, Viader F, et al. Three-dimensional surfacemapping of hippocampal atrophy progression fromMCItoADand over normal aging as assessed using voxel-based morphometry. Neuropsychologia 2008;46:1721-31.
10. Csernansky JG, Wang L, Joshi S, Miller JP, Gado M, Kido D, et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Dementia of the Alzheimer type. Neurology 2000;55:1636-43.
11. De Leon MJ, George AE, Golomb J, Tarshish C, Convit A, Kluger A, et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging 1997;18:1-11.
12. Frisoni GB, Ganzola R, Canu E, Rub U, Pizzini FB, Alessandrini F, et al. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 2008;131:3266-76.
13. Jack CR Jr, DicksonDW, Parisi JE, Xu YC, Cha RH, O'Brien PC, et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002;58:750-7.
14. Jack CR Jr, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000;55:484-9.
15. Jack CR Jr, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999;52:1397-403.
16. Frisoni GB, Jack CR. Harmonization of magnetic resonance-based manual hippocampal segmentation: A mandatory step for wide clinical use. Alzheimers Dement 2011;7:171-4.
17. Boccardi M, Ganzola R, Bocchetta M, Pievani M, Redolfi A, Bartzokis G, et al. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J Alzheimers Dis 2011;26(Suppl 3):61-75.
18. Boccardi M, Bocchetta M, Apostolova LG, et al. Establishing MRI orientation for the EADC-ADNI manual hippocampal segmentation protocol. J Neuroimaging 2014;24:509-14.
19. Boccardi M, Bocchetta M, Apostolova LG, Barnes J, Bartzokis G, Corbetta G, et al. Delphi Definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance. Alzheimers Dement 2015;11:126-38.
20. Boccardi M, Bocchetta M, Apostolova LG, Preboske G, Robitaille N, Pasqualetti P, et al. Establishing magnetic resonance images orientation for the EADC-ADNI manual hippocampal segmentation protocol. J Neuroimaging 2014;24:509-14.
21. Bocchetta M, Boccardi M, Ganzola R, Apostolova LG, Preboske G, Wolf D, et al. Harmonized benchmark labels of the hippocampus on magnetic resonance: The EADC-ADNI project. Alzheimers Dement 2015;11:151-65.
22. Duchesne S, Valdivia F, Robitaille N, Mouiha A, Abiel Valdivia F, Bocchetta M, et al. Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project. Alzheimers Dement 2015;11:161-74.
23. Frisoni GB, Jack CR, Bocchetta M, Bauer C, Frederiksen KS, Liu Y, et al. The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: Evidence of validity. Alzheimers Dement 2015;11:111-25.
24. Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: A review of the literature. J Neuropathol Exp Neurol 2012; 71:362-81.
25. Nelson PT, Braak H, Markesbery WR. Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship. J Neuropathol Exp Neurol 2009;68:1-14.
26. Whitwell JL, Dickson DW, Murray ME, Weigand SD, Tosakulwong N, Senjem ML, et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: A case-control study. Lancet Neurol 2012;11:868-77.
27. Whitwell JL, Josephs KA, Murray ME, Kantarci K, Przybelski SA, Weigand SD, et al. MRI correlates of neurofibrillary tangle pathology at autopsy: A voxel-based morphometry study. Neurology 2008; 71:743-9.
28. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991;1:103-16.
29. Bobinski M, Wegiel J, Wisniewski HM, Tarnawski M, Reisberg B, Mlodzik B, et al. Atrophy of hippocampal formation subdivisions correlates with stage and duration of Alzheimer disease. Dementia 1995; 6:205-10.
30. Schonheit B, Zarski R, Ohm TG. Spatial and temporal relationships between plaques and tangles in Alzheimer-pathology. Neurobiol Aging 2004;25:697-711.
31. Braak H, Braak E. Staging of Alzheimer-related cortical destruction. Int Psychogeriatr 1997;9(Suppl 1):257-61. discussion 69-72.
32. Braak H, Braak E, Bohl J. Staging of Alzheimer-related cortical destruction. Eur Neurol 1993;33:403-8.
33. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
34. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol 1996;92:197-201.
35. Mirra SS, Gearing M, McKeel DW Jr, Crain BJ, Hughes JP, van Belle G, et al. Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: A study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD). J Neuropathol Exp Neurol 1994;53:303-15.
36. Zarow C, Vinters HV, Ellis WG, Weiner MW, Mungas D, White L, et al. Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol 2005;57:896-903.
37. West MJ, Gundersen HJ. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol 1990;296:1-22.
38. Harding AJ, Halliday GM, Kril JJ. Variation in hippocampal neuron number with age and brain volume. Cereb Cortex 1998;8:710-8.
39. Simic G, Kostovic I, Winblad B, Bogdanovic N. Volume and number of neurons of the human hippocampal formation in normal aging and Alzheimer's disease. J Comp Neurol 1997;379:482-94.
40. West MJ, Coleman PD, Flood DG, Troncoso JC. Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet 1994;344:769-72.
41. von Gunten A, Kovari E, Bussiere T, Rivara CB, Gold G, Bouras C, et al. Cognitive impact of neuronal pathology in the entorhinal cortex and CA1 field in Alzheimer's disease. Neurobiol Aging 2006; 27:270-7.
42. Padurariu M, Ciobica A, Mavroudis I, Fotiou D, Baloyannis S. Hippocampal neuronal loss in the CA1 and CA3 areas of Alzheimer's disease patients. Psychiatria Danubina 2012;24:152-8.
43. West MJ, Kawas CH, Stewart WF, Rudow GL, Troncoso JC. Hippocampal neurons in pre-clinical Alzheimer's disease. Neurobiol Aging 2004;25:1205-12.
44. Thal DR, Rub U, Schultz C, Sassin I, Ghebremedhin E, Del Tredici K, et al. Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol 2000;59:733-48.
45. Hof PR, Glannakopoulos P, Bouras C. The neuropathological changes associated with normal brain aging. Histol Histopathol 1996; 11:1075-88.
46. Giannakopoulos P, Hof PR, Mottier S, Michel JP, Bouras C. Neuropathological changes in the cerebral cortex of 1258 cases from a geriatric hospital: Retrospective clinicopathological evaluation of a 10-year autopsy population. Acta Neuropathol 1994;87:456-68.
47. Back SA, Kroenke CD, Sherman LS, Lawrence G, Gong X, Taber EN, et al. White matter lesions defined by diffusion tensor imaging in older adults. Ann Neurol 2011;70:465-76.
48. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci U S A 1999;96:14079-84.
49. Dhenain M, Privat N, Duyckaerts C, Jacobs RE. Senile plaques do not induce susceptibility effects in T2∗-weightedMRmicroscopic images. NMR Biomed 2002;15:197-203.
50. Ekstrom AD, Bazih AJ, Suthana NA, Al-Hakim R, Ogura K, Zeineh M, et al. Advances in high-resolution imaging and computational unfolding of the human hippocampus. NeuroImage 2009; 47:42-9.
51. Zeineh MM, Engel SA, Thompson PM, Bookheimer SY. Unfolding the human hippocampus with high resolution structural and functional MRI. Anat Rec 2001;265:111-20.
52. Pluta J, Yushkevich P, Das S, Wolk D. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semiautomatic segmentation of T2-weighted MRI. J Alzheimers Dis 2012;31:85-99.
53. Yassa MA, Mattfeld AT, Stark SM, Stark CE. Age-related memory deficits linked to circuit-specific disruptions in the hippocampus. Proc Natl Acad Sci U S A 2011;108:8873-8.
54. Mueller SG, Weiner MW. Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus 2009; 19:558-64.
55. Amaral R, Augustinack JC, Bender AR, et al. Quantitative comparison of 21 protocols for labeling hippocampal subfields and parahippocampal cortical subregions in in vivo MRI: Towards developing a Harmonized Segmentation Protocol. Neuroimage 2014 (Ms. No.: NIMG-14- 2271, I revision). Supplementary.